Innospec Inc. reported a decrease in total revenues for Q4 2020 to $310.8 million, a 20% decrease compared to $390.7 million in Q4 2019. Net income was $22.6 million, or $0.91 per diluted share, compared to $31.1 million, or $1.26 per diluted share in the same quarter last year. Adjusted non-GAAP EPS was $1.27 per diluted share, compared to $1.47 per diluted share a year ago.
Continued strong revenue growth and operating income in Performance Chemicals.
Further sequential improvement in sales and operating income for Fuel Specialties.
Oilfield Services returned to positive operating income.
Excellent cash generation enhanced strong liquidity position; Improvement in net cash to $104.7 million.
The pandemic continues to add uncertainty to the general economic outlook, but as regions reopen and commercial activity increases, Innospec expects that demand for its products will continue to improve in all of its businesses. The company has prioritized new, technology-based, organic investment opportunities for 2021 and continues to evaluate acquisition opportunities focused on expanding its presence in the diverse number of end-markets.
Visualization of income flow from segment revenue to net income